Open Access
- 22 September 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (19) , 10186
Abstract
Gap junctions (GJ) and connexins play integral roles in cellular physiology and have been found to be involved in multiple pathophysiological states from cancer to cardiovascular disease. Studies over the last 60 years have demonstrated the utility of altering GJ signaling pathways in experimental models, which has led to them being attractive targets for therapeutic intervention. A number of different mechanisms have been proposed to regulate GJ signaling, including channel blocking, enhancing channel open state, and disrupting protein-protein interactions. The primary mechanism for this has been through the design of numerous peptides as therapeutics, that are either currently in early development or are in various stages of clinical trials. Despite over 25 years of research into connexin targeting peptides, the overall mechanisms of action are still poorly understood. In this overview, we discuss published connexin targeting peptides, their reported mechanisms of action, and the potential for these molecules in the treatment of disease.Keywords
All Related Versions
Funding Information
- American Heart Association (19CDA34630036)
- National Institutes of Health (R01-AA025854, R01-HL137112)
This publication has 212 references indexed in Scilit:
- The Liver Connexin32 Interactome Is a Novel Plasma Membrane-Mitochondrial Signaling NexusJournal of Proteome Research, 2013
- Role of connexins in human congenital heart disease: the chicken and egg problemFrontiers in Pharmacology, 2013
- Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injuryBasic Research in Cardiology, 2012
- Connexin43 phosphorylation and cytoprotection in the heartBiochimica et Biophysica Acta (BBA) - Biomembranes, 2012
- Phosphorylation of Connexin 50 by Protein Kinase A Enhances Gap Junction and Hemichannel FunctionJournal of Biological Chemistry, 2011
- Design and characterization of the first peptidomimetic molecule that prevents acidification-induced closure of cardiac gap junctionsHeart Rhythm, 2010
- Enhanced connexin 43 expression delays intra‐mitoitc duration and cell cycle traverse independently of gap junction channel functionJournal of Cellular Biochemistry, 2010
- Characterization of the Structure and Intermolecular Interactions between the Connexin40 and Connexin43 Carboxyl-terminal and Cytoplasmic Loop DomainsJournal of Biological Chemistry, 2009
- Connexin43 phosphorylation: structural changes and biological effectsBiochemical Journal, 2009
- Chapter 2 Biological and Biophysical Properties of Vascular Connexin Channels2009